Medical Marijuana Use for Long COVID Symptoms

Written By

Natalie Reyes

As researchers continue studying the long-term effects of COVID-19, millions of individuals worldwide are still experiencing lingering health complications commonly referred to as “long COVID” or post-COVID conditions. The Centers for Disease Control and Prevention (CDC) defines long COVID as a range of symptoms that can persist for weeks, months, or even years following an initial COVID-19 infection [1]. Common symptoms include chronic fatigue, sleep disturbances, muscle and joint pain, anxiety, depression, and cognitive impairment often described as “brain fog” [2]. Because conventional treatment options remain limited and highly individualized, interest in medical marijuana for long COVID symptoms and other cannabis-based therapies has steadily increased.

Researchers are currently exploring how cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) interact with the body’s endocannabinoid system, which helps regulate pain perception, inflammation, mood, sleep, and immune function [3]. However, experts caution that current evidence remains limited, and cannabis should not be considered a cure or substitute for professional medical treatment [4].

Learn More: CBD and COVID-19

Understanding Long COVID Symptoms

Long COVID, also known as post-COVID conditions, refers to a broad range of physical, neurological, and psychological symptoms that continue or develop after an initial COVID-19 infection [5]. According to the World Health Organization (WHO), symptoms may persist for months and significantly interfere with daily activities and overall quality of life [6]. Commonly reported symptoms include chronic fatigue, muscle and joint pain, sleep disturbances, shortness of breath, anxiety, depression, and cognitive dysfunction commonly referred to as “brain fog” [7].

One of the primary challenges associated with long COVID treatment is that symptoms vary widely from person to person, making standardized treatment approaches difficult [8]. Conventional therapies typically focus on symptom-specific management rather than a single targeted treatment. As a result, researchers are increasingly studying whether cannabinoids such as CBD and THC may provide supportive benefits related to inflammation, sleep quality, stress response, and chronic discomfort. However, experts emphasize that cannabis for long COVID symptoms remains an emerging area of research that requires further clinical investigation [9].

Why Medical Marijuana Is Being Explored

As interest in alternative therapies for long COVID symptom management grows, researchers are increasingly examining the potential role of medical marijuana and cannabis-derived compounds such as CBD and THC [9]. Much of this interest centers around the body’s endocannabinoid system (ECS), a complex cell-signaling network involved in regulating pain perception, immune response, mood, sleep, appetite, and inflammation [10]. Because many long COVID symptoms, including chronic pain, fatigue, anxiety, sleep disturbances, and inflammation-related discomfort, overlap with processes influenced by the ECS, researchers believe cannabinoids may offer supportive therapeutic potential worthy of further investigation [4].

CBD is frequently studied for its potential anti-inflammatory and calming properties, while THC has been explored for its effects on pain perception, appetite stimulation, nausea, and sleep support [11]. Medical cannabis products are available in several forms, including oils, tinctures, capsules, edibles, vaporizers, and topicals. This variety allows healthcare providers and patients to individualize cannabis use based on symptom severity, tolerance, and treatment goals. Despite growing interest, experts stress that research involving cannabis for long COVID symptoms is still in its early stages, and more large-scale clinical trials are needed to better understand effectiveness, safety, dosage considerations, and long-term outcomes [12].

Potential Benefits for Long COVID Symptom Management

Although research on medical marijuana for long COVID symptoms is still developing, early findings and patient-reported experiences suggest cannabis-based therapies may offer supportive benefits for certain persistent symptoms [9]. Researchers are investigating whether cannabinoids such as CBD and THC may help address issues related to chronic pain, inflammation, sleep disturbances, anxiety, and reduced appetite, all of which are commonly associated with long COVID [4]. CBD has gained attention for its potential calming and anti-inflammatory properties, while THC has been studied for its possible role in pain relief, appetite stimulation, and sleep support [11].

For some patients, improving sleep quality and reducing stress levels may contribute to a better overall quality of life during long COVID recovery. However, responses to cannabis can vary significantly depending on dosage, cannabinoid profile, individual tolerance, underlying health conditions, and method of consumption [13]. Healthcare experts emphasize that cannabis for long COVID symptom management should be approached cautiously and under professional medical supervision, especially because current clinical evidence remains limited and outcomes can differ widely between individuals [12].

Risks, Limitations, and Current Research

While interest in medical marijuana for long COVID symptoms continues to grow, healthcare experts caution that current scientific evidence remains limited and inconclusive [9]. Most existing studies involving cannabis for long COVID symptom management are preliminary, observational, or based on symptom overlap rather than large-scale clinical trials specifically focused on long COVID patients [4]. In addition, medical marijuana may cause side effects in some individuals, including dizziness, fatigue, impaired coordination, dry mouth, cognitive impairment, and changes in mood or heart rate, particularly with higher THC concentrations [14]. Cannabis may also interact with certain prescription medications, making physician supervision especially important for individuals managing chronic conditions or multiple treatments.

Because cannabinoid potency, labeling accuracy, and contaminant testing are not always consistent across products, patients are encouraged to purchase only lab-tested medical cannabis products from licensed dispensaries where legally available [15]. Researchers continue to study the long-term safety and potential therapeutic role of cannabinoids such as CBD and THC in long COVID recovery, but experts agree that more controlled clinical research is still needed before definitive conclusions can be made [12].

Tips for Patients Considering Medical Marijuana

Patients interested in using medical marijuana for long COVID symptoms should first consult a qualified healthcare professional familiar with both cannabis medicine and post-COVID conditions [15]. Because long COVID symptoms can vary significantly between individuals, medical guidance is important for evaluating potential risks, medication interactions, and appropriate cannabinoid formulations. Many experts recommend a “start low and go slow” approach when beginning cannabis for long COVID symptom management, particularly with THC-containing products, to help minimize unwanted side effects and better assess tolerance [14].

Patients are also encouraged to purchase lab-tested medical cannabis products from licensed dispensaries where quality-control standards are in place [12]. Keeping a symptom journal may help individuals monitor changes in sleep quality, pain levels, mood, fatigue, and overall wellness while evaluating how different CBD or THC products affect their symptoms over time. Although research on cannabis and long COVID continues to evolve, informed decision-making and physician supervision remain essential for safe and responsible use [9].

In Summary

As interest in medical marijuana for long COVID symptoms continues to rise, researchers are working to better understand how cannabinoids such as CBD and THC may support symptom management for issues including chronic pain, sleep disturbances, anxiety, inflammation, and fatigue [4]. While early medical cannabis research and patient-reported experiences show promising areas for further study, experts emphasize that current evidence remains limited and should not be interpreted as proof of effectiveness or a cure for long COVID [9]. Because long COVID symptoms can differ greatly between individuals, treatment approaches, including cannabis-based therapies, should be personalized and medically supervised whenever possible.

As additional clinical studies emerge, healthcare providers and researchers hope to gain a clearer understanding of the safety, risks, and potential therapeutic role of medical marijuana in post-COVID recovery [12].


References

Natalie Reyes
Natalie Reyes brings over a decade of experience in the cannabis industry and is a leading contributor to several respected cannabis publications. A strong advocate for legal, safe cannabis use and consumer education, she is known for delivering informed, research-driven insights across the evolving industry landscape. Natalie remains actively involved in major cannabis events nationwide, serving as a keynote speaker and mentoring the next generation of cannabis professionals.